Source link : https://newshealth.biz/health-news/nice-endorses-vutrisiran-for-attr-cm-treatment/
NICE has recommended vutrisiran for routine NHS use in adults with transthyretin amyloidosis with cardiomyopathy, offering a new disease-modifying option alongside tafamidis. Medscape News UK Source link : https://www.medscape.com/viewarticle/nice-endorses-vutrisiran-attr-cm-treatment-2025a1000wi7?src=rss Author : Publish date : 2025-11-21 13:49:00 Copyright for syndicated content belongs to the linked Source.
The post NICE Endorses Vutrisiran for ATTR-CM Treatment first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-21 13:49:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8